Clinical Trial Update: Acamprosate in Alcoholics With Comorbid Anxiety or Depression [Phase 4]

View source ↗

Summary

Phase 4 study evaluating acamprosate in individuals with alcohol use disorder and coexisting anxiety or depressive disorders; results have been posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Generalized Anxiety Disorder
• Major Depressive Disorder
• Social Anxiety Disorder

Drugs mentioned

• Campral (acamprosate)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Dependence, Major Depression | Phase 4 | Status: COMPLETED | Results posted: 2015-04-13